Sale!

CD3G Gene Cone-Rod Dystrophy Type 17 Genetic Test

Name: CD3G Gene Cone-Rod Dystrophy Type 17 Genetic Test
SKU: TEST-962
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CD3G Gene Cone-Rod Dystrophy Type 17 Genetic Test” is a specialized diagnostic procedure aimed at identifying mutations in the CD3G gene, which are implicated in Cone-Rod Dystrophy Type 17, a rare genetic disorder. This condition affects the retina, leading to the progressive loss of vision starting with color vision deficits, decreased visual acuity, and loss of peripheral vision, eventually progressing to blindness. The test is crucial for early diagnosis, which can aid in management and understanding the prognosis of the disease.

Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the CD3G gene to detect any abnormalities that could indicate the presence of Cone-Rod Dystrophy Type 17. The test cost is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene. This genetic test is a vital tool for individuals with a family history of the condition or those experiencing symptoms, offering them a clear diagnosis and the possibility of genetic counseling based on their results.

Description

CD3G Gene Cone-rod dystrophy type 17 Genetic Test

Test Name: CD3G Gene Cone-rod dystrophy type 17 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ophthalmology Disorders

Doctor: Ophthalmologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test gene CD3G

Test Details: The CD3G gene is associated with cone-rod dystrophy type 17 (CORD17), which is a rare genetic disorder that affects the retina. CORD17 is characterized by progressive loss of vision, initially affecting the cones (responsible for color vision and visual acuity) and later the rods (responsible for peripheral vision and low light vision). NGS (next-generation sequencing) genetic testing is a type of DNA testing that can analyze multiple genes simultaneously. It involves sequencing the entire coding region of a gene, as well as the adjacent non-coding regions that may contain regulatory elements. NGS genetic testing for CD3G gene mutations can help diagnose CORD17 and identify carriers of the disease. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling.

Test Name	CD3G Gene Cone-rod dystrophy type 17 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ophthalmology Disorders
Doctor	Ophthalmologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test gene CD3G
Test Details	The CD3G gene is associated with cone-rod dystrophy type 17 (CORD17), which is a rare genetic disorder that affects the retina. CORD17 is characterized by progressive loss of vision, initially affecting the cones (responsible for color vision and visual acuity) and later the rods (responsible for peripheral vision and low light vision). NGS (next-generation sequencing) genetic testing is a type of DNA testing that can analyze multiple genes simultaneously. It involves sequencing the entire coding region of a gene, as well as the adjacent non-coding regions that may contain regulatory elements. NGS genetic testing for CD3G gene mutations can help diagnose CORD17 and identify carriers of the disease. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling.